Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA2Z5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,260
Award facts
- Contract value 100% obligated
- $15,260.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,260.01 to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors. This is a firm fixed-price, non-set-aside contract with a completion date of January 21, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, particularly the Defense Logistics Agency's Medical Supply Chain.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract value up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. AmerisourceBergen's success in securing this and similar awards reflects its capability to compete in open competition and efficiently fulfill critical medical supply requirements for federal military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FA2Z5?
SPE2DR26FA2Z5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FA2Z5 worth?
The government has obligated $15,260 on SPE2DR26FA2Z5.
Is contract SPE2DR26FA2Z5 an order under another contract?
Yes. SPE2DR26FA2Z5 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2Z5 competed?
The extent of competition for SPE2DR26FA2Z5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award